The Unyvero platform developed by Curetis is a fast, comprehensive diagnostics system for severe infectious diseases in hospitalized patients. Using a variety of cartridges, diseases such as pneumonia or implant and tissue infections can be easily and rapidly diagnosed within just 4–5 hours, whether this is in the hospital laboratory or directly at the "point of need" in the intensive care unit.
You can find out more about Unyvero here.
Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology
Curetis subsidiary Ares Genetics wins incubator stay in Silicon Valley
Deutsche Biotechnologietage 2018 - Berlin, Germany - April 18 to 19, 2018
28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid, Spain - 21 to 24 April, 2018